文献速递脑血管病

黑种人与轻型缺血性卒中或短暂性脑缺血发作后早期复发的关联:POINT随机临床试验二次分析

Association of Black Race With Early Recurrence After Minor Ischemic Stroke or Transient Ischemic Attack: Secondary Analysis of the POINT Randomized Clinical Trial.
PubMed 文献 · JAMA Neurol · 2020-01-01

该研究基于POINT试验的4044例美国患者数据,分析黑种人与轻型缺血性卒中或高危短暂性脑缺血发作后90天内缺血性卒中复发的关联。结果显示,校正多种混杂因素后,黑种人复发风险高于白种人(HR 1.6,95%CI 1.1-2.3),亚组分析结果一致。

要点

  • 黑种人轻型卒中或TIA后90天内缺血性卒中复发风险高于白种人。
  • 校正年龄、性别、血管危险因素等后,HR为1.6(95%CI 1.1-2.3)。
  • 应努力确保黑种患者获得已证实有效的二级预防措施。

核心结论

  • 在美国POINT试验参与者中,黑种人在轻型缺血性卒中或TIA后早期卒中复发风险高于白种人。
  • 研究结果支持进一步研究黑种人与白种人复发卒中潜在机制的差异。

研究设计与样本

  • 队列研究,分析POINT随机临床试验数据,该试验在269个中心开展,时间为2010年5月28日至2017年12月19日。
  • 试验纳入4881例成人,发病12小时内且NIHSS评分0-3分的轻型缺血性卒中或ABCD2评分≥4分的高危TIA。
  • 本分析排除598例美国以外入组患者和239例种族/民族数据缺失的美国患者,最终纳入4044例。

主要发现

  • 纳入分析的4044例患者中,918例(22.7%)为黑种人。
  • 校正Cox模型中,黑种人相比白种人复发风险更高(HR 1.6;95%CI 1.1-2.3)。
  • 亚组分析和仅限于纳入黑种人患者的中心分析结果相似。

关键数值与推荐

  • 主要结局为随机化后90天内缺血性卒中。
  • 协变量包括年龄、性别、西班牙裔、氯吡格雷vs安慰剂分组、指数事件为卒中vs TIA、血管危险因素、他汀使用、研究药物依从性和指数事件病因亚型。

临床怎么用

  • 对黑种人轻型缺血性卒中或TIA患者应加强早期二级预防,确保其获得已证实有效的预防措施。
  • 临床可关注黑种人复发风险较高这一差异,但本研究未阐明具体机制。

局限性

  • 本研究为POINT试验的二次分析,排除了美国以外入组患者及种族数据缺失者。
  • 原文未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Stroke incidence is higher among black than white individuals in the United States. It is unclear whether black individuals have a higher risk of stroke recurrence after a minor ischemic stroke or transient ischemic attack (TIA), a high-risk setting in which focused preventive efforts can be effective. OBJECTIVE: To examine the association between black race and early ischemic stroke recurrence. DESIGN, SETTING, AND PARTICIPANTS: This cohort study analyzed data from the Platelet Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) trial conducted at 269 sites from May 28, 2010, to December 19, 2017. The trial enrolled 4881 adults within 12 hours of onset of a minor ischemic stroke (National Institutes of Health Stroke Scale score, 0-3) or high-risk TIA (ABCD2 score, ≥4). For this analysis, we excluded 598 patients enrolled outside the United States and 239 US patients with missing race/ethnicity data. MAIN OUTCOMES AND MEASURES: The primary outcome for this analysis was ischemic stroke within 90 days after randomization. Covariates included age, sex, Hispanic ethnicity, study assignment to take clopidogrel vs placebo, index stroke vs TIA, vascular risk factors, statin use, study drug adherence, and index event etiological subtype. RESULTS: Among 4044 patients included in the analysis, 918 (22.7%) were black. In an adjusted Cox model, black race was associated with a higher risk of recurrence compared with white race (hazard ratio, 1.6; 95% CI, 1.1-2.3). Findings were similar in subgroup analyses and in analyses limited to sites that enrolled black patients. CONCLUSIONS AND RELEVANCE: Among US participants in the POINT trial, black individuals faced a higher risk of early stroke recurrence after a minor ischemic stroke or TIA. Our findings support research into black-white racial differences in the underlying mechanisms of recurrent stroke. In the meantime, extra effort should be made to ensure that black patients have access to proven secondary prevention measures. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00991029.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Kamel H, Zhang C, Kleindorfer DO, et al. Association of Black Race With Early Recurrence After Minor Ischemic Stroke or Transient Ischemic Attack: Secondary Analysis of the POINT Randomized Clinical Trial. JAMA Neurol. 2020. PMID: 32091536. doi:10.1001/jamaneurol.2020.0010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。